Actual Medicinal Product (AMP) Vokanamet 50mg/850mg tablets (Napp Pharmaceuticals Ltd)

Stability Information

(Some stability information inherited from generic)

Stability
compatible_special_measures logo Lack of data and/or stability concerns exist. MCA use may be acceptable but is likely to be off-label and require mitigation measures. Keep medicines in MCAs for the shortest time necessary. Generally, up to 5 weeks maximum unless otherwise specified, or up to 8 weeks if the MCA is airtight (sealed). Consider the risk of potency loss or dose variability and monitor for changes in efficacy or adverse effects after MCA initiation.
Notes

Original packaging may contain desiccant. Anecdotal reports of use in MCAs for up to 30 days.

Provenance

This recommendation is based on the products Vokanamet 50 mg/850 mg film-coated tablets (A. Menarini Farmaceutica Internazionale SRL)

Generic
Canagliflozin + Metformin
Formulation
Canagliflozin 50mg / Metformin 850mg tablets
  • Canagliflozin + Metformin
    • Canagliflozin 50mg / Metformin 850mg tablets

      • Vokanamet 50mg/850mg tablets (Napp Pharmaceuticals Ltd)